Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells

Carcinogenesis

Volumn 26, Issue 11, 2005, Pages 1978-1987

  Tyagi, Alpna ^a   Singh, Rana P ^a   Agarwal, Chapla ^a,b   Siriwardana, Sunitha ^b,c   Sclafani, Robert A ^b,c   Agarwal, Rajesh ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CAFFEINE; CELL CYCLE PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN DEPENDENT KINASE; PROTEIN TYROSINE PHOSPHATASE; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL CULTURE; CELL CYCLE S PHASE; CELL DIVISION; CELL LINE; DNA DAMAGE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOSIS INHIBITION; MOLECULAR MECHANICS; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATAXIA TELANGIECTASIA; CDC2 PROTEIN KINASE; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEOTIDE REDUCTASES; S PHASE; SIGNAL TRANSDUCTION; STILBENES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; TYROSINE;

EID: 27744485649     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi165     Document Type: Article

References (49)

1. Jemal,A., Tiwari,R.C., Murray,T., Ghafoor,A., Samuels,A., Ward,E., Feuer,E.J. and Thun,M.J. (2004) Cancer statistics, 2004. CA Cancer J. Clin., 54, 8-29.
2. Surh,Y.J. (2003) Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 3, 768-780.
3. Burns,J., Yokota,T., Ashihara,H., Lean,M.E. and Crozier,A. (2002) Plant foods and herbal sources of resveratrol. J. Agric. Food Chem., 22, 3337-3340.
4. Pervaiz,S. (2001) Resveratrol - from the bottle to the bedside? Leuk. Lymphoma, 40, 491-498.
5. Jang,M., Cai,L., Udeani,G.O. et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
6. Kuwajerwala,N., Cifuentes,E., Gautam,S., Menon,M., Barrack,E.R. and Reddy,G.P. (2002) Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res., 62, 2488-2492.
7. Estrov,Z., Shishodia,S., Faderl,S., Harris,D., Van,Q., Kantarjian,H.M. and Talpaz,M. (2003) Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 102, 987-995.
8. Sgambato,A., Ardito,R., Faraglia,B., Boninsegna,A., Wolf,F.I. and Cittadini,A. (2001) Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat. Res., 496, 171-180.
9. Opipari,A.W.,Jr, Tan,L., Boitano,A.E., Sorenson,D.R., Aurora,A. and Liu,J.R. (2004) Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res., 64, 696-703.
10. Juan,M.E., Vinardell,M.P. and Planas,J.M. (2002) The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr., 132, 257-260.
11. Aggarwal,B.B., Bhardwaj,A., Aggarwal,R.S., Seeram,N.P., Shishodia,S. and Takada,Y. (2004) Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res., 24, 2783-2840.
12. Bove,K., Lincoln,D.W. and Tsan,M.F. (2002) Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun., 29, 1001-1005.
13. Fukuhara,K. and Miyata,N. (1998) Resveratrol as a new type of DNA-cleaving agent. Bioorg. Med. Chem. Lett., 22, 3187-3192.
14. Elledge,S.J. (1996) Cell cycle checkpoints: Preventing an identity crisis. Science, 274, 1664-1672.
15. Zhou,B.B. and Elledge,S.J. (2000) The DNA damage response: Putting checkpoints in perspective. Nature, 408, 433-439.
16. Kastan,M.B. and Lim,D.S. (2000) The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol., 1, 179-186.
17. Abraham,R.T. (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 15, 2177-2196.
18. O'Neill,T., Giarratani,L., Chen,P., Iyer,L., Lee,C.H., Bobiak,M., Kanai,F., Zhou,B.B., Chung,J.H. and Rathbun,G.A. (2002) Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J. Biol. Chem., 277, 16102-16115.
19. Liu,Q., Guntuku,S., Cui,X.S. et al. (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev., 14, 1448-1459.
20. Zhao,H. and Piwnica-Worms,H. (2001) ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol., 21, 4129-4139.
21. Kastan,M.B. (2004) ATM - the first step in helping cells deal with DNA damage. Biomed. Pharmacother., 58, 72-73.
22. Bulavin,D.V., Higashimoto,Y., Demidenko,Z.N. et al. (2003) Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat. Cell Biol., 6, 545-551.
23. 2 arrest in human cells. J. Cell Biol., 134, 963-970.
24. Jin,P., Hardy,S. and Morgan,D.O. (1998) Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol., 141, 875-885.
25. Grimison,B., Langan,T.A. and Sclafani,R.A. (2000) P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution. Cell Growth Differ., 11, 507-515.
26. Todd,M.C., Sclafani,R.A. and Langan,T.A. (2000) Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein. Oncogene, 19, 258-264.
27. Shiloh,Y. (2003) ATM and related protein kinases: Safeguarding genome integrity. Nat. Rev. Cancer, 3, 155-168.
28. Khanna,K.K., Lavin,M.F., Jackson,S.P. and Mulhern,T.D. (2001) ATM, a central controller of cellular responses to DNA damage. Cell Death Differ., 8, 1052-1065.
29. Saito,S., Goodarzi,A.A., Higashimoto,Y., Noda,Y., Lees-Miller,S.P., Appella,E. and Anderson,C.W. (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem., 277, 12491-12494.
30. Sarkaria,J.N., Busby,E.C., Tibbetts,R.S., Roos,P., Taya,Y., Karnitz,L.M. and Abraham,R.T. (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res., 59, 4375-4382.
31. Matsuoka,S., Huang,M. and Elledge,S.J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 282, 1893-1897.
32. Parker,L.L. and Piwnica-Worms,H. (1992) Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science, 257, 1955-1957.
33. Mueller,P.R., Coleman,T.R. and Dunphy,W.G. (1995) Cell cycle regulation of a Xenopus Wee1-like kinase. Mol. Biol. Cell, 6, 119-134.
34. Kharbanda,S., Saleem,A., Hirano,M., Emoto,Y., Sukhatme,V., Blenis,J. and Kufe,D. (1994) Activation of early growth response 1 gene transcription and pp90rsk during induction of monocytic differentiation. Cell Growth Differ., 5, 259-265.
35. 2 delay induced by the exogenous factors epidermal growth factor and phorbol ester. J. Cell. Physiol., 168, 589-599.
36. Burma,S., Chen,B.P., Murphy,M., Kurimasa,A. and Chen,D.J. (2001) ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem., 276, 42462-42467.
37. Willett,W.C. (1994) Diet and health: What should we eat? Science, 264, 532-537.
38. Block,G., Patterson,B. and Subar,A. (1992) Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer, 18, 1-29.
39. Waladkhani,A.R. and Clemens,M.R. (1998) Effect of dietary phytochemicals on cancer development. Int. J. Mol. Med., 1, 747-753.
40. Kelloff,G.J., Crowell,J.A., Steele,V.E. et al. (2000) Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents. J. Nutr., 130, 467S-471S.
41. Soleas,G.J., Diamandis,E.P. and Goldberg,D.M. (1997) Wine as a biological fluid: History, production, and role in disease prevention. J. Clin. Lab. Anal., 11, 287-313.
42. Khanna,K.K. and Jackson,S.P. (2001) DNA double-strand breaks: Signaling, repair and the cancer connection. Nat. Genet., 27, 247-254.
43. Ahn,J.Y., Schwarz,J.K., Piwnica-Worms,H. and Canman,C.E. (2000) Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res., 60, 5934-5936.
44. Matsuoka,S., Rotman,G., Ogawa,A., Shiloh,Y., Tamai,K. and Elledge,S.J. (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl Acad. Sci. USA, 97, 10389-10394.
45. Lopez-Girona,A., Furnari,B., Mondesert,O. and Russell,P. (1999) Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature, 397, 172-175.
46. 2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501-1505.
47. Russell,P. and Nurse,P. (1987) The mitotic inducer nim1+ functions in a regulatory network of protein kinase homologs controlling the initiation of mitosis. Cell, 49, 569-576.
48. Kumagai,A. and Dunphy,W.G. (1991) The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell, 64, 903-914.
49. 2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J. Biol. Chem., 279, 25813-25822.